These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 18771092)
21. Modulation of HIV reservoirs by host HLA: bridging the gap between vaccine and cure. Brumme ZL; Chopera DR; Brockman MA Curr Opin Virol; 2012 Oct; 2(5):599-605. PubMed ID: 22939190 [TBL] [Abstract][Full Text] [Related]
22. Pathogenic infection of Rhesus macaques by an evolving SIV-HIV derived from CCR5-using envelope genes of acute HIV-1 infections. Asmal M; Lane S; Tian M; Nickel G; Venner C; Dirk B; Dikeakos J; Luedemann C; Mach L; Balachandran H; Buzby A; Rao S; Letvin N; Gao Y; Arts EJ Virology; 2016 Dec; 499():298-312. PubMed ID: 27723488 [TBL] [Abstract][Full Text] [Related]
23. Viral correlates of HIV-1 disease. Anastassopoulou CG; Kostrikis LG Curr HIV Res; 2005 Apr; 3(2):113-32. PubMed ID: 15853718 [TBL] [Abstract][Full Text] [Related]
24. Virulence and pathogenesis of HIV-1 infection: an evolutionary perspective. Fraser C; Lythgoe K; Leventhal GE; Shirreff G; Hollingsworth TD; Alizon S; Bonhoeffer S Science; 2014 Mar; 343(6177):1243727. PubMed ID: 24653038 [TBL] [Abstract][Full Text] [Related]
25. Molecular epidemiology of HIV-1 genetic forms and its significance for vaccine development and therapy. Thomson MM; Pérez-Alvarez L; Nájera R Lancet Infect Dis; 2002 Aug; 2(8):461-71. PubMed ID: 12150845 [TBL] [Abstract][Full Text] [Related]
26. Rapid virus dissemination in infant macaques after oral simian immunodeficiency virus exposure in the presence of local innate immune responses. Abel K; Pahar B; Van Rompay KK; Fritts L; Sin C; Schmidt K; Colón R; McChesney M; Marthas ML J Virol; 2006 Jul; 80(13):6357-67. PubMed ID: 16775324 [TBL] [Abstract][Full Text] [Related]
27. Innate immunity against HIV-1 infection. Altfeld M; Gale M Nat Immunol; 2015 Jun; 16(6):554-62. PubMed ID: 25988887 [TBL] [Abstract][Full Text] [Related]
29. Implications of HIV diversity for the HIV-1 pandemic. Hemelaar J J Infect; 2013 May; 66(5):391-400. PubMed ID: 23103289 [TBL] [Abstract][Full Text] [Related]
30. AIDS/HIV. Developing an AIDS vaccine: need, uncertainty, hope. Emini EA; Koff WC Science; 2004 Jun; 304(5679):1913-4. PubMed ID: 15218131 [No Abstract] [Full Text] [Related]
31. Intra-host evolution of human immunodeficiency virus type 1 and viral fitness. Clementi M; Canducci F; Bagnarelli P; Menzo S New Microbiol; 2004 Apr; 27(2 Suppl 1):41-4. PubMed ID: 15646063 [TBL] [Abstract][Full Text] [Related]
32. The clades of HIV: their origins and clinical significance. Stebbing J; Moyle G AIDS Rev; 2003; 5(4):205-13. PubMed ID: 15011999 [TBL] [Abstract][Full Text] [Related]
33. Curtailing the AIDS pandemic. Mullins JI Science; 1997 Jun; 276(5321):1955-7. PubMed ID: 9221490 [No Abstract] [Full Text] [Related]
34. Living in oblivion: HIV immune evasion. Piguet V; Trono D Semin Immunol; 2001 Feb; 13(1):51-7. PubMed ID: 11289799 [TBL] [Abstract][Full Text] [Related]
35. HIV vaccines under study. Ravanfar P; Mendoza N; Satyaprakash A; Jordan BI Dermatol Ther; 2009; 22(2):158-67. PubMed ID: 19335727 [TBL] [Abstract][Full Text] [Related]
36. Progress towards an HIV-1 subtype C vaccine. Nkolola JP; Essex M Vaccine; 2006 Jan; 24(4):391-401. PubMed ID: 16139396 [TBL] [Abstract][Full Text] [Related]
37. An African HIV-1 sequence from 1959 and implications for the origin of the epidemic. Zhu T; Korber BT; Nahmias AJ; Hooper E; Sharp PM; Ho DD Nature; 1998 Feb; 391(6667):594-7. PubMed ID: 9468138 [TBL] [Abstract][Full Text] [Related]
38. Protection against chronic infection and AIDS by an HIV envelope peptide-cocktail vaccine in a pathogenic SHIV-rhesus model. Nehete PN; Chitta S; Hossain MM; Hill L; Bernacky BJ; Baze W; Arlinghaus RB; Sastry KJ Vaccine; 2001 Dec; 20(5-6):813-25. PubMed ID: 11738745 [TBL] [Abstract][Full Text] [Related]